Call Options on ASH on 1/18/2022

Ashland Global Holdings Inc. (ASH) provides additives and specialty ingredients worldwide.

It operates through Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents segments.

The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; and nutraceutical solutions comprising products for weight management, joint comfort, stomach and intestinal health, sports nutrition, and general wellness, as well as custom formulation, toll processing, and particle engineering solutions.

The Personal Care & Household segment provides a range of nature-based, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers.

The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding.

The Intermediates and Solvents segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. Ashland Global Holdings Inc. offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical.

The company was formerly known as Ashland Inc. and changed its name to Ashland Global Holdings Inc. in September 2016.

Please note, this stock reports earnings on Tuesday, February 8th.

Ashland Global Holdings reported Quarter September 2021 earnings of $1.22 per share on revenue of $591.0 million. The consensus earnings estimate was $1.28 per share on revenue of $640.7 million. Revenue fell 3.0% compared to the same quarter a year ago.

The company said it expects fiscal 2022 revenue of $2.25 billion to $2.35 billion. The current consensus revenue estimate is $2.42 billion for the year ending September 30, 2022.

This stock has done a very great job at handling adversity in the midst of the pandemic and continues to remain strong as it sits above an all-time high.

Last Trade: $105.70

Trading Range: $79.16 - $110.74

Trade Buy 1 February $105.00 Call at $3.50 For a net debit of $3.50 Profit/Loss Analysis Breakeven at $108.50 Maximum profit is unbounded Maximum loss is ($350.00) at strike of $105.00 Closing Summary Sold 1 February $105.00 Call at $3.51

Position closed on 3/11/2022 at price of $3.51 with a 0.29% gain in 52 days.

Back to Portfolio